Why the study?
Does stepped management with disopyramide and/or septal reduction therapy improve symptoms, gradients, and survival in patients with obstructive hypertrophic cardiomyopathy resistant to beta-blockers or verapamil?
Population
299 patients with obstructive hypertrophic cardiomyopathy and limiting symptoms resistant to first-line…
Comparison
Stepped management including addition of… vs Nonobstructed hypertrophic cardiomyopathy…
Design
Cohort
Follow-up
4.8 years
Authors
Loading...
Supports stepped therapy in refractory obstructive HCM; hypothesis-generating without randomized confirmation.
Does stepped management with disopyramide and/or septal reduction therapy improve symptoms, gradients, and survival in patients with obstructive hypertrophic cardiomyopathy resistant to beta-blockers or verapamil?
Stepped management with disopyramide and surgical myectomy provides excellent long-term survival and symptom relief in patients with obstructive HCM refractory to first-line medical therapy.
Sherrid et al. (2013) studied this question.